Mustafa Demir

Dr. Mustafa Demir

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Medicine
Verified
Journal Article
Open access
MDMustafa Demir
Mustafa Demir
ASAslihan Semiz-Oysu
Aslihan Semiz-Oysu
EOEda Ozsezen
Eda Ozsezen
YYYunus Yasar
Yunus Yasar
This study aims to evaluate the role of <50% stenotic cervical carotid artery plaques in embolic stroke of undetermined source (ESUS), focusing on plaque characteristics in symptomatic versus asymptomatic carotid arteries (contralateral). In this cross-sectional observational study, 81 patients who met the diagnostic criteria for ESUS and underwent were retrospectively analyzed. Carotid plaques causing <50% stenosis were examined, noting features such as plaque thickness, degree of luminal stenosis, irregularity, ulceration, calcification, and hypodensity. These characteristics were compared between the ipsilateral and contralateral carotid arteries. The study involved 33 men and 48 women, with plaques ≥3mm thick significantly more common in the ipsilateral carotid arteries (P < .05). Notable features such as plaque ulceration, irregularity, noncalcified plaque, and hypodensity were significantly more frequent ipsilaterally (P < .05). Of the plaque patients, 54.3% (44/81) were on the ipsilateral side, compared to 29.6% (24/81) on the contralateral side (P = .0024). Our findings underscore the potential significance of non-stenotic carotid plaques in ESUS. These plaques, especially those with certain high-risk characteristics, are more prevalent ipsilaterally and should be considered in clinical evaluations and treatment of ESUS.

20 November 2025 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
YYYunus Yasar
Yunus Yasar
MDMustafa Demir
Mustafa Demir
ATAhmet Harun Turgan
Ahmet Harun Turgan
ACAli Cantürk
Ali Cantürk

19 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
YYYunus Yasar
Yunus Yasar
SESevde Nur Emir
Sevde Nur Emir
MEMuhammet Rasit Er
Muhammet Rasit Er
MDMustafa Demir
Mustafa Demir
Background/Objectives: Multimodal large language models (LLMs) may directly interpret medical images, including thyroid ultrasounds (USs). Whether these models can reliably assess thyroid nodules—where subtle echogenic and morphological details are critical—remains uncertain. The American College of Radiology (ACR) TI-RADS system provides a structured framework for benchmarking artificial intelligence. This study evaluates GPT-5.0’s ability to interpret thyroid US images according to TI-RADS criteria and contextualizes its performance relative to expert radiologist assessment, using FNA cytology as the reference standard. Methods: This retrospective study included 100 patients (mean age 49.8 ± 12.6 years; 72 women) with cytology-confirmed diagnoses: Bethesda II (benign) or Bethesda V–VI (malignant). Each nodule had longitudinal and transverse US images acquired with high-frequency linear probes. A board-certified radiologist (>10 years’ experience) and GPT-5.0 independently assessed TI-RADS features (composition, echogenicity, shape, margin, echogenic foci) and assigned final categories. Agreement was analyzed using Cohen’s κ, and diagnostic performance was calculated using TR4–TR5 as positive for malignancy. Results: Agreement was substantial for composition (κ = 0.62), shape (κ = 0.70), and margin (κ = 0.68); moderate for echogenicity (κ = 0.48); and poor for echogenic foci (κ = 0.12). GPT-5.0 demonstrated a systematic, risk-averse tendency to up-classify nodules, leading to increased TR4–TR5 assignments. Overall, the TI-RADS agreement was 58% (κ = 0.31). The radiologist showed superior diagnostic performance (sensitivity 89%, specificity 85%) compared with GPT-5.0 (sensitivity 67%, specificity 49%), largely driven by false-positive TR4 classifications among benign nodules. Conclusions: GPT-5.0 recognizes several high-level TI-RADS features but struggles with microcalcifications and tends to overestimate malignancy risk within a risk-stratification framework, limiting its standalone clinical use. Ultrasound-specific training and domain adaptation may enable meaningful adjunctive roles in thyroid nodule assessment.

1 January 2025 in Northern Clinics of Istanbul
Verified
Journal Article
Open access
MDMustafa Demir
Mustafa Demir
MAMehmet Taha Avci
Mehmet Taha Avci
AAAbdulbaki Agackiran
Abdulbaki Agackiran
SESevdenur Emir
Sevdenur Emir
AAAylin Acar
Aylin Acar
TCTolga Canbak
Tolga Canbak
Microwave ablation (MWA) has emerged as a minimally invasive treatment for hepatocellular carcinoma (HCC), offering a promising alternative for patients ineligible for surgical resection. This study aims to evaluate the efficacy, safety, and clinical outcomes of MWA in a single-center cohort, focusing on treatment success, recurrence rates, and long-term survival. A retrospective analysis was conducted on 54 patients who underwent percutaneous ultrasound-guided MWA for HCC between January 2019 and December 2023. Patient demographics, tumor characteristics, and procedural outcomes were assessed. Treatment success was defined as complete ablation confirmed by contrast-enhanced imaging one month post-procedure. Local tumor progression (LTP) and recurrence rates were evaluated during follow-up. Survival outcomes were analyzed based on follow-up data, considering overall survival and recurrence-free survival rate. A total of 71 tumors were treated in 54 patients. Complete ablation was achieved in 91.5% of tumors following the initial or secondary procedure. LTP was observed in 16.6% of patients during follow-up. No major complications were reported. The median follow-up period was 36 months, and survival outcomes were comparable to those reported for other ablative techniques. No statistically significant correlation was found between tumor size and ablation success (p>0.05). MWA is an effective and safe treatment modality for HCC, demonstrating high technical success and acceptable recurrence rates. These findings support the continued integration of MWA in multidisciplinary HCC management, particularly for patients ineligible for surgery. Further research with larger cohorts and longer follow-up is needed to optimize patient selection and refine ablation strategies.

23 January 2026 in Tomography
Verified
Journal Article
Open access
PDF file
MDMustafa Demir
Mustafa Demir
YYYunus Yasar
Yunus Yasar
Objective: The number of operators performing mechanical thrombectomy (MT) may influence procedural outcomes; however, evidence remains limited and conflicting. This study aimed to comprehensively evaluate the impact of single versus dual operators on procedure time, radiation dose, and angiographic success in patients undergoing MT for acute ischemic stroke. Methods: In this single-center, retrospective cohort study, 285 consecutive patients who underwent MT for large-vessel occlusion between January 2020 and December 2024 were included. Patients were grouped according to institutional workflow: single-operator procedures (n = 157) and dual-operator procedures (n = 128). The primary endpoints were procedure time and radiation dose parameters, including total Kerma-Area Product (PKA). Secondary endpoints included successful reperfusion (TICI ≥ 2b), complete reperfusion (TICI 3), and first-pass success (FPS, defined as TICI 2c/3 with a single pass). Results: Baseline characteristics were comparable between groups. The dual-operator group had significantly shorter median procedure times (52.5 vs. 85.0 min, p < 0.001) and lower total PKA (p < 0.001). Reperfusion rates were significantly higher in the dual-operator group, both for successful reperfusion (TICI ≥ 2b: 80.5% vs. 64.3%, p = 0.004) and complete reperfusion (TICI 3: 76.6% vs. 58.5%, p = 0.002). First-pass success was also more frequent (60.0% vs. 44.5%, p = 0.0146), and the mean number of passes was lower (1.66 vs. 2.00, p = 0.0057). Conclusions: Mechanical thrombectomy performed with two experienced operators was associated with greater procedural efficiency, reduced patient radiation exposure, and higher angiographic success compared with single-operator procedures. These findings support considering the dual-operator model as an approach that may inform workforce planning and workflow decisions in stroke centers.

30 December 2024 in The Turkish Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
SUSıla Atamyıldız Uçar
Sıla Atamyıldız Uçar
MDMustafa Demir
Mustafa Demir
BSBetul Sozeri
Betul Sozeri
Background. Polyarteritis nodosa (PAN) is a rare and serious form of systemic necrotizing vasculitis that predominantly affects medium and small-sized arteries, with central nervous system involvement being particularly uncommon. Treatment strategies are tailored according to the extent and severity of the disease. While conventional therapy includes glucocorticoids and conventional disease-modifying-rheumatic drugs (cDMARDs), biologic agents may be critical for severe and refractory cases. Case. We report a case of systemic PAN in a 7-year-old girl with no prior medical history, who presented with fever, abdominal pain, and altered mental status. Initial investigations with cranial MRI and echocardiography suggested encephalitis and myocarditis, respectively. Positive SARS-CoV-2 antibodies in both cerebrospinal fluid and serum oriented the diagnosis towards multisystem inflammatory syndrome in children. Despite intensive conventional therapies with glucocorticoids, cDMARDs, and intravenous immunoglobulins, the patient’s condition deteriorated. Elevated von Willebrand factor levels, hypertension, and proteinuria emerged, along with stable intracranial hemorrhage and abdominal organ infarctions on imaging, leading to the diagnosis of PAN. Cyclophosphamide was added to the treatment regimen. Three cranial aneurysms were identified on selective conventional cranial angiography. Following angiography, severe intraparenchymal bleeding was detected, leading to emergency cranial surgery. Unresponsiveness to conventional therapeutics led to treatment escalation with a tumor necrosis factor inhibitor, infliximab, resulting in clinical stabilization and allowing for successful endovascular coil embolization. Conclusion. This case highlights the importance of considering a tumor necrosis factor inhibitor, infliximab, in severe PAN with involvement of intracranial aneurysm.